Birch pollen allergoid - Allergopharma

Drug Profile

Birch pollen allergoid - Allergopharma

Alternative Names: Allergovit Birch; Birch pollen allergy immunotherapy - Allergopharma

Latest Information Update: 30 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Allergopharma
  • Class Allergens; Antiallergics; Peptide vaccines; Peptides; Tree pollen allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Seasonal allergic rhinitis

Most Recent Events

  • 30 Mar 2017 Allergopharma completes a phase II trial for Seasonal allergic rhinitis in Germany (SC) (EudraCT2015-005400-28)
  • 20 Jun 2016 Allergopharma initiates a phase II trial for Seasonal allergic rhinitis in Germany (SC) (EudraCT2015-005400-28)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top